Platelet Function With Various Storage Techniques
Sponsor
Northwell Health (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03338660
Collaborator
(none)
0
3
24
Study Details
Study Description
Brief Summary
Platelet function will be tested in individuals on antiplatelet medications to determine the optimal storage methodology.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2 |
Detailed Description
Subjects will undergo administration of antiplatelet drugs and then will receive platelets stored in a variety of methods. Platelet function will be measured serially.
Study Design
Study Type:
Interventional
Actual Enrollment
:
0 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
crossover study of various storage infusions techniques with each subject receiving various fluids aliquots.crossover study of various storage infusions techniques with each subject receiving various fluids aliquots.
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
the assesor of platelet function and the PI will be blinded to group.
Primary Purpose:
Treatment
Official Title:
The Impact of Various Storage Techniques on Platelet Function
Anticipated Study Start Date
:
Jul 15, 2018
Anticipated Primary Completion Date
:
Jul 15, 2019
Anticipated Study Completion Date
:
Jul 15, 2020
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Placebo Comparator: Control (Placebo) Subjects will receive infusion of placebo (saline). |
Biological: Placebo
Subjects will receive infusion placebo (saline).
Other Names:
|
Active Comparator: Platelet storage routine Subjects will receive infusion of platelets stored by routine method. |
Biological: Infusion of Platelets
Platelets will be stored using the routine platelet storage method. Subjects will receive infusion of platelets stored by routine storage method.
Other Names:
|
Experimental: Platelet storage experimental Subjects will receive infusion of platelets stored by a novel methodology. |
Biological: Infusion of Platelets
Platelets will be stored using novel, FDA approved, technique. Subjects will receive infusion of platelets stored by novel technique, routine storage, and placebo (saline).
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Change in platelet function [1 hour post-transfusion]
Frozen platelets will result in improvement in platelet function after transfusion.
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Normal subjects
Exclusion Criteria:
- Pre existing antiplatelet drugs
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Northwell Health
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Northwell Health
ClinicalTrials.gov Identifier:
NCT03338660
Other Study ID Numbers:
- 16-XXXX-SIUHN
First Posted:
Nov 9, 2017
Last Update Posted:
May 29, 2019
Last Verified:
May 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No